The encapsulated yeast Cryptococcus neoformans is a significant cause of opportunistic infection in patients with impaired cell-mediated immunity. The major virulence determinant of the organism is an antiphagocytic polysaccharide capsule synthesized after entry into the host. Using both an encapsulated virulent strain and an acapsular avirulent mutant, we have demonstrated the reduced ability of the encapsulated strain to stimulate specific T-cell responses in vitro. This reduction was mediated by the antiphagocytic action of the capsule rather than by direct inhibition of antigen processing and presentation, since prior opsonization with complement enhanced the ingestion of encapsulated yeast cells by purified antigen-presenting cells and allowed significant T-cell activation. Once ingestion had occurred, cryptococci were efficiently processed by activated macrophages via a chloroquine-sensitive pathway. Cryptococcal antigens were available for T-cell recognition within 1 to 2 h of interaction with macrophages and presented in a major histocompatibility complex-restricted manner. Our results suggest that the antiphagocytic action of the polysaccharide capsule is an important determinant for the development of T-cell immunity to C. neoformans.
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Cryptococcus neoformans is an encapsulated yeast that is an increasingly frequent cause of opportunistic infection as a consequence of human immunodeficiency virus infection (5, 7) . The organism enters the host via inhalation of a small, acapsular form into the lung, where it can produce a localized subclinical infection or disseminate throughout other organ systems, frequently resulting in lethal meningitis. A primary virulence determinant of C. neoformans is the synthesis of an antiphagocytic polysaccharide capsule after inhalation by the host (9) . Nonencapsulated mutants of C. neoformans are avirulent in experimental models of infection and are readily phagocytosed by host macrophages (8, 11, 26) . In contrast, capsule synthesis by virulent C. neoformans impairs ingestion by phagocytic cells (2, 18, 21) , although this can be partially overcome by opsonization with complement (6, 22) or specific anticapsule antibody (19) .
Clinical and experimental evidence has implicated T lymphocytes in the resistance of the immunocompetent host to C. neoformans. Thus, although infection can occur in apparently immunocompetent individuals, the majority of cases are associated with impaired cell-mediated immunity states such as AIDS. Experimental evidence also supports a primary role for T cell-dependent resistance, since athymic nude mice show increased susceptibility to infection (4, 14) and resistance in normal animals is dependent on the presence of CD4+ T cells in vivo (17, 27) . However, previous studies of T-cell immunity to C. neoformans have focused on delayed-type hypersensitivity responses in vivo (10, 13, 16, 25) or the development of T cell-mediated suppressor cell networks (28) . In the present study we have extended these observations by investigating the characteristics of T-cell activation by C. neoformans in vitro.
The mechanisms of antigen processing required for the development of T-cell immunity to fungal pathogens such as C. neoformans have not been defined. Since most processing events occur intracellularly (30, 31) , C. neoformans poses * Corresponding author. unique problems to the host due to the antiphagocytic action of its polysaccharide capsule, which is also suggested to have immunosuppressive properties (3, 20, 28, 29) . Cryptococcal polysaccharides are found at high concentrations in the serum and cerebrospinal fluid of patients (12) and have been correlated with suppression of delayed-type hypersensitivity in a murine model of infection (28) For analysis of macrophage ingestion of C. neoformans, heat-killed organisms were washed three times in R10 and added in 100-pld volumes to macrophage monolayers, the plates were spun at 1,100 rpm (300 x g) for 1 min and incubated at 37°C for 2 h, and the cells were washed to remove nonbound or ingested organisms. Absolute methanol (100 ,ul) was added to each well for 10 min at room temperature to permeabilize the cells, and the cell monolayer was washed with phosphate-buffered saline (PBS)-5% donor calf serum (PBS-DCS). All antibody staining was done in 35-pul volumes at 4°C for 30 min. Rabbit anti-C. neoformans capsule antibody (Alpha Laboratories) diluted 1:500 in PBS-DCS or rabbit anti-C. neoformans cell wall antibody at 100 ,ug/ml was added to each well. After the cells were washed with PBS-DCS, goat anti-rabbit immunoglobulin conjugated with tetramethylrhodamine isothiocyanate (Nordic Immunologicals) and diluted 1:40 in PBS-DCS was added; the cells were then washed and stored at 4°C in PBS. Fluorescence was visualized by using an inverted fluorescence microscope, and the number of organisms bound or ingested per 100 macrophages was calculated by using the following formula: (total number of organisms stained red/total number of macrophages per field) x 100.
C. neoformans-specific T-cell proliferation and antigen processing. Popliteal lymph nodes were harvested from mice 7 days after priming as described above. The cells were washed three times in R1-10 mM nonessential amino acids (GIBCO)-1 mM sodium pyruvate (GIBCO) and diluted to 5 x 106/ml. Cells were added to flat-bottomed microtiter plates in 100-,lI volumes, and 100 ,ul of stimulus or medium was added. After incubation at 37°C for 36 h, the cells were pulsed with 0.5 RCi of [methyl-3H]thymidine (Amersham) per well and incubated for 32 h. Cells were harvested with a PHD cell harvester (Cambridge Technologies), and thymidine incorporation was measured by counting in a Beckman LS800 liquid scintillation counter.
To investigate antigen processing requirements, peritoneal exudate cells activated in vivo 5 days previously by intraperitoneal injection of 200 ,ug of ConA were harvested, plated at 3 x 105 per well in 96-well flat-bottomed plates in R10, allowed to adhere for 2 h at 37°C, and used throughout as antigen-presenting cells. All washing steps involved four changes of medium per well. After the macrophage monolayer was washed, C. neoformans preopsonized in normal mouse serum or medium alone was added, and the plates were spun at 1,100 rpm for 1 min. After incubation at 37°C for 2 h, monolayers were washed to remove nonbound organisms and incubated at 37°C to allow processing to occur. At appropriate times, processing was halted by the addition of 100 RI of 2% paraformaldehyde (Sigma) in PBS per well for 10 min at room temperature. Cells were washed, 100 RI of 0.1 M lysine (Sigma) diluted in R10 was added, the cells were incubated at 37°C for 15 min, and the washing was repeated. Further incubation in R10 at 37°C for at least 2 h removed the excess paraformaldehyde and prevented toxic effects from reducing the T-cell response. Primed popliteal lymph node cells were harvested and prepared at 5 x 106/ml in R10-10 mM nonessential amino acids-1 mM sodium pyruvate. The cells were added to antigen-pulsed presenting cell monolayers in 100-,u volumes, and 100 ,ul of medium was added per well. T-cell proliferation (thymidine incorporation) was measured after 3 days as described above. In inhibition experiments, chloroquine (Sigma) was added to the monolayers for 30 min before the yeasts were added and remained in culture for the entire processing time.
In experiments investigating the effect of purified CPS on the intracellular processing of an unrelated antigen, hen egg white lysozyme (HEL; Sigma), the procedure was followed as described previously (24) . In summary, CPS was added to macrophage monolayers for 2 to 3 h before incubation with HEL for 90 min. The HEL-specific T-cell hybridoma 3A9 (kindly donated by P. Allen, Washington University, St. Louis, Mo.) was added, and interleukin-2 production was assayed after 24 h by a modification of the method previously described (1). Erythrocyte-depleted spleen cells from CBA mice were incubated at 106/ml in the presence of 1 ,ug of ConA per ml for 3 days. After three washes, the T-cell blasts were resuspended to 4 x 105/ml and plated in 50-,ul volumes in round-bottomed Flow tissue culture plates. The supernatants to be assayed were added in 50-,u volumes, the cells were incubated at 37°C for 24 h (the last 4 h in the presence of [3H]thymidine) and then harvested, and the proliferation was measured as described above.
RESULTS
Development of specific T-cell responses against C. neoformans. Initial experiments established optimal methods for enumeration and for determining the growth and characteristics of the organism. The two strains of C. neoformans used in this study differ in surface properties and virulence.
The virulent B3501 organism is encapsulated, whereas the avirulent B4131 strain is a stable, acapsular mutant derived from the encapsulated parent strain. Flow cytometric analysis indicated that 89% of B3501 cells stained positive with a rabbit anti-capsular antibody, compared with 3% of B4131 cells.
To determine the optimal conditions for the development of T cells that are reactive against C. neoformans, mice were primed with heat-killed acapsular organisms in vivo followed by in vitro stimulation of lymph node cells with intact C. neoformans. Initially, the acapsular form of the organism was selected to remove any potentially suppressive effects of the capsule. Injection of 5 x 107 heat-killed organisms in incomplete Freund adjuvant resulted in the formation of lymph node cells that were reactive against cryptococcal antigens when challenged in vitro with 1 x 106 heat-killed acapsular organisms. Control mice injected with saline and adjuvant showed no reactive cells, demonstrating the requirement for cell priming and the absence of any mitogenic activity of C. neoformans in vitro (C. neoformans plus adjuvant, 16.8 ± 0.6 kcpm; saline plus adjuvant, 2.6 ± 0.2 kcpm; medium alone, 1.4 ± 0.1 kcpm). Similar proliferative responses to soluble cryptococcal antigen were observed (data not shown). Spleen lymphocytes reactive against C. neoformans were also produced after infection with live acapsular organisms, although the magnitude of the proliferative response was less than that in adjuvant-primed animals (C. neoformans-infected mice, 10.1 ± 1.1 kcpm; salineinjected mice, 2.6 ± 0.2 kcpm). The production of the T cell-derived cytokines interleukin-2 and gamma interferon by the responding lymph node cells suggested that the response to cryptococcal antigens was T cell mediated (data not shown).
To assess the effect of the polysaccharide capsule on the stimulation of specific T cells, both forms of the organism were compared for their ability to stimulate primed lymph node cells in vitro. B4131-primed lymph node cells showed a proliferative response to the acapsular organism but no stimulation above background levels after the addition of intact encapsulated C. neoformans (Fig. 1) . In other experiments, 30-fold more encapsulated organisms were required to induce cell proliferation (data not shown). This was not due to an obvious difference in antigenicity between the two organisms, because the proliferation in response to soluble antigen preparations derived from both strains were identical. These results suggested that the capsule of intact yeast cells inhibited the in vitro stimulation of C. neoformansspecific T cells.
Effect of the polysaccharide capsule on processing of C. neoformans antigens. Since intracellular processing of complex protein antigens is usually required before inducing T-cell activation, encapsulation of C. neoformans could inhibit ingestion or degradation by antigen-presenting cells. Therefore a system was established to characterize the requirements for processing of C. neoformans by macrophage antigen-presenting cells. Initial experiments with acapsular organisms showed that macrophages activated in vivo with ConA for 5 days processed intact yeast cells and presented cryptococcal antigens to primed lymph node cells in a dose-dependent manner (Fig. 2) . Viable antigen-presenting cells were required for this response, since fixation with 2% paraformaldehyde before pulsing with antigen abolished lymphocyte proliferation, excluding the contribution of already degraded antigens in the preparation of the organisms used. Purification of the lymph node cell population by passage over nylon wool resulted in T-cell enrichment, as The macrophage antigen-presenting cell system described above was then used to compare the efficiency of processing and presentation to primed lymph node cells of opsonized encapsulated versus acapsular C. neoformans. In terms of the actual number of organisms ingested per antigen-presenting cell, the capsule had no effect on the ability of macrophages to process cryptococcal antigens (Fig. 3) ; 10 organisms ingested per 100 macrophages were sufficient to induce T-cell proliferation. Furthermore, yeast cells cultured in conditions that increased capsule synthesis were also processed and presented with an efficiency equal to that for acapsular organisms once ingested by the macrophage pre- senting cells (data not shown). In other experiments, equivalent ingestion of unopsonized and opsonized encapsulated C. neoformans was achieved by the addition of a 10-fold excess of unopsonized organisms. Under these conditions, no difference in lymph node proliferation was observed (8.1 ± 0.4 kcpm versus 7.8 ± 0.2 kcpm at 75 and 70 yeasts bound or ingested per 100 macrophages, respectively), demonstrating that opsonization per se had no intrnnsic effect on the efficiency of antigen processing, other than to increase antigen uptake. Finally the addition of 1 mg of purified CPS from C. neoformans had no effect on the ability of ConAactivated macrophages to process and present an independent protein antigen, HEL (HEL plus medium, 12.1 ± 1.8 kcpm; HEL plus CPS, 11.6 ± 2.0 kcpm). Together, these experiments suggest that, provided ingestion of the organism by the presenting cell occurs, the capsule has no effect on the processing and presentation of cryptococcal antigens and subsequent T-cell activation.
Characterization of antigen-processing events for C. neoformans. The characteristics of antigen processing for T-cell responses to fungal pathogens have not been previously described. Here, processed cryptococcal antigen was available for T-cell recognition within 1 to 2 h after the interaction of intact yeast cells with the antigen-presenting cells (Fig. 4) . These events were major histocompatibility complex (MHC) restricted, because proliferation of specific lymph node cells was reduced after interaction with C. neoformans-pulsed antigen-presenting cells prepared from mice with a different MHC haplotype (Fig. 5) . It is established that class II MHC-restricted processing events are inhibited by the addition of lysosomotropic agents to the antigen-presenting cell. Antigen-presenting cells treated with chloroquine before the addition of live opsonized encapsulated yeast cells resulted in reduced proliferation of C. neoformans-specific lymph node cells (Fig. 6) . Thus, presentation of C. neoformans antigens initially requires an intracellular processing event similar to that previously described for soluble protein antigens and bacteria (31, 32) . DISCUSSION In the present study, T cells responsive to cryptococcal antigens were elicited after in vivo priming of mice with the acapsular form of the organism. Primed lymph node cells proliferated equally well in response to soluble antigens prepared from either acapsular or encapsulated C. neoformans. In contrast, proliferation induced by intact encapsulated yeast cells was greatly reduced in comparison with that induced by the acapsular mutant, suggesting that capsule synthesis impaired T-cell activation, possibly by interfering with either uptake or processing and presentation by antigen-presenting cells.
To address the mechanism of impaired T-cell responsiveness, we established a model to study the processing and presentation of cryptococcal antigens in vitro. In experiments with purified macrophages as antigen-presenting cells, encapsulation of C. neoformans was also associated with (0) 
